STOCK TITAN

Gossamer Bio cuts shareholder quorum to one-third

Gossamer Bio’s board lowered the stockholder meeting quorum requirement to one-third of voting power under newly amended bylaws.

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Gossamer Bio, Inc. (GOSS) reports that its Board of Directors approved an amendment and restatement of the company’s bylaws, effective September 3, 2026. The Amended and Restated Bylaws reduce the stockholder meeting quorum requirement from holders of a majority to holders of one third (1/3) in voting power of the company’s capital stock issued and outstanding and entitled to vote, present in person, by remote communication if applicable, or represented by proxy, unless a higher threshold is required by law, the certificate of incorporation, or the bylaws.

Positive

  • None.

Negative

  • None.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
New quorum threshold One third (1/3) in voting power Quorum requirement for Gossamer Bio stockholder meetings under Amended and Restated Bylaws
Prior quorum threshold Majority in voting power Previous quorum requirement for Gossamer Bio stockholder meetings before September 3, 2026
Effective date of bylaw amendment September 3, 2026 Date the Board approved and made effective the Amended and Restated Bylaws
Amended and Restated Bylaws regulatory
"approved the amendment and restatement of the amended and restated bylaws of the Company"
A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.
quorum regulatory
"to reduce the requisite quorum at all meetings of stockholders"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
voting power financial
"from the holders of a majority to the holders of one third (1/3) in voting power"
Voting power is the ability shareholders have to influence a company's major decisions—like electing the board, approving mergers, or changing corporate rules—based on the voting rights attached to the shares they hold. For investors it matters because greater voting power is like holding more keys to a building: it gives you a stronger say over management choices and the company’s strategy, which can affect future value and risk.
Nasdaq Global Select Market market
"Common Stock, $0.0001 par value per share | GOSS | Nasdaq Global Select Market"
A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

What governance change did Gossamer Bio (GOSS) announce on September 3, 2026?

Gossamer Bio’s Board approved Amended and Restated Bylaws that lower the quorum requirement for stockholder meetings from a majority to one third (1/3) of the company’s voting power, effective September 3, 2026.

What is the new quorum requirement for GOSS stockholder meetings?

The new quorum requirement is the holders of one third (1/3) in voting power of Gossamer Bio’s capital stock issued and outstanding and entitled to vote, present in person, by remote communication if applicable, or represented by proxy, unless a higher threshold is otherwise required.

When did Gossamer Bio’s Amended and Restated Bylaws become effective?

The Amended and Restated Bylaws became effective on September 3, 2026, the same date the Board of Directors approved the changes to the quorum requirement for stockholder meetings.

Does the new quorum rule at GOSS apply in all circumstances?

The one third (1/3) quorum applies unless otherwise required by applicable law, Gossamer Bio’s certificate of incorporation, or the Amended and Restated Bylaws, which may mandate a higher quorum for certain matters.

On which exchange is Gossamer Bio (GOSS) listed and what class of stock is affected?

Gossamer Bio’s Common Stock, $0.0001 par value per share, trades under the symbol GOSS on the Nasdaq Global Select Market. The new quorum requirement applies to capital stock entitled to vote at stockholder meetings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0001728117FALSE12/3100017281172026-09-032026-09-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 3, 2026
GOSSAMER BIO, INC.
(Exact name of Registrant as Specified in Its Charter)
 
Delaware001-3879647-5461709
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)(IRS Employer
Identification No.)
3115 Merryfield Row, Suite 120
San Diego, California 92121

(Address of Principal Executive Offices) (Zip Code)
(858) 684-1300
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per shareGOSSNasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On and effective as of September 3, 2026, the Board of Directors (the “Board”) of Gossamer Bio, Inc. (the “Company”) approved the amendment and restatement of the amended and restated bylaws of the Company (as so amended and restated, the “Amended and Restated Bylaws”) to reduce the requisite quorum at all meetings of stockholders for the transaction of business from the holders of a majority to the holders of one third (1/3) in voting power of the Company’s capital stock issued and outstanding and entitled to vote, present in person, or by remote communication, if applicable, or represented by proxy, unless otherwise required by applicable law, the Company’s certificate of incorporation or the Amended and Restated Bylaws.

The foregoing description of the Amended and Restated Bylaws is qualified in its entirety by reference to the full text of the Amended and Restated Bylaws, a copy of which is attached as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.
Description


3.1

Amended and Restated Bylaws of Gossamer Bio, Inc.
104

Cover Page Interactive Data File (embedded within the Inline XBRL document)







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
GOSSAMER BIO, INC.
Date: September 3, 2026By:/s/ Christian Waage
Christian Waage
Executive Vice President and General Counsel


Filing Exhibits & Attachments

4 documents